Q1 2024 · 13F-HR
First Turn Management, LLCholdings as filed
Filed 2024-05-06 · accession 0001085146-24-002247
$668.5M
Reported value
34
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 82489T104 | SWAVUSD | SHOCKWAVE MED INC | $31.9M | 4.78% | 98,111 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $31.5M | 4.71% | 79,978 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $30.2M | 4.51% | 430,349 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $29.3M | 4.38% | 680,389 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $28.7M | 4.29% | 221,748 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $27.3M | 4.08% | 342,173 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $26.8M | 4.00% | 192,932 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $25.7M | 3.84% | 394,674 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $25.2M | 3.78% | 379,803 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $24.6M | 3.68% | 58,832 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $24.1M | 3.60% | 958,654 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $23.6M | 3.54% | 432,342 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $23.3M | 3.48% | 130,850 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $22.9M | 3.43% | 151,587 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $22.0M | 3.29% | 297,377 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $21.8M | 3.26% | 1,318,207 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $20.0M | 2.99% | 265,897 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $18.3M | 2.73% | 421,487 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $17.8M | 2.66% | 260,281 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $17.6M | 2.64% | 464,435 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $17.5M | 2.61% | 397,782 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $16.6M | 2.48% | 512,893 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $15.7M | 2.35% | 252,673 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $15.7M | 2.34% | 973,130 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $15.1M | 2.26% | 1,097,571 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $14.3M | 2.14% | 206,707 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $14.0M | 2.09% | 1,179,420 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $13.7M | 2.04% | 990,618 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $12.8M | 1.92% | 228,251 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $12.1M | 1.81% | 585,447 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $10.5M | 1.57% | 128,064 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $6.8M | 1.01% | 250,870 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $6.3M | 0.94% | 381,210 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $5.1M | 0.76% | 118,260 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.